Femtech dealmaking is on the mend.
After a period of investor skittishness, deals for startups catering to women’s and reproductive health have bounced back and already surpassed 2023’s total deal value, according to PitchBook data. So far this year, $980 million has been deployed across 64 deals, up from the previous year’s total of $840 million from 94 deals.
The US Supreme Court’s decision in June 2022 that eliminated the constitutional right to an abortion and triggered bans in over a dozen states drummed up enthusiasm in the sector. But a swell of legal challenges and a poor fundraising environment challenged that momentum.
Now, some large deals are signaling renewed interest. Flo Health, a period tracking and reproductive health startup, raised a $200 million Series C led by General Atlantic in July, bringing its valuation above $1 billion. In September, Business Insider reported that Maven, a telehealth startup for women and families, was raising over $100 million from StepStone.
Here are the the 10 most active investors in the femtech sector since 2019.
Featured image by Joey Schaffer/PitchBook News
Learn more about our editorial standards.
